NT
Nareshkumar Talsibhai Dhanvania
About Nareshkumar Talsibhai Dhanvania
Data last updated:
Nareshkumar Talsibhai Dhanvania is a Director at Piecan Pharma Private Limited (since 2016) and Director at Kapasi Pharma Private Limited (since 2021). The companies operate in Pharma. The largest current company by reported revenue is Piecan Pharma Private Limited at ₹5.52 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 May 2016 | 2016 | ₹5.52 Cr (FY 2023) | Active | |
| Director | 10 Sep 2021 | 2021 | Active |
Board colleagues of Nareshkumar Talsibhai Dhanvania
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rahulkumar Makvana | 10676072 | Piecan Pharma Private Limited | Additional Director |
| Vinodrai Himmatlal Kapasi | 07138178 | Kapasi Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nareshkumar Talsibhai Dhanvania
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nareshkumar Talsibhai Dhanvania
Nareshkumar Talsibhai Dhanvania currently holds 2 directorships: Piecan Pharma Private Limited (Director, since 31 May 2016, revenue ₹5.52 Cr (FY 2023)); Kapasi Pharma Private Limited (Director, since 10 Sep 2021).
Nareshkumar Talsibhai Dhanvania was first appointed on 31 May 2016 as Director at Piecan Pharma Private Limited. The most recent appointment on record is 10 Sep 2021 at Kapasi Pharma Private Limited.
The current boards of Nareshkumar Talsibhai Dhanvania's companies include Rahulkumar Makvana (Piecan Pharma Private Limited), Vinodrai Himmatlal Kapasi (Kapasi Pharma Private Limited).